Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged >=35 years: a randomized controlled trial
2000 ◽
Vol 73
(5)
◽
pp. 908-912
◽
2014 ◽
Vol 12
(1)
◽
pp. 17
◽